Your browser doesn't support javascript.
loading
Expert survey on management of prostate cancer in India: Real-world insights into practice patterns.
Bakshi, Ganesh; Tongaonkar, Hemant; Addla, Sanjai; Menon, Santosh; Pradhan, Aditya; Kumar, Abhay; Bapat, Abhijit; Gore, Adwaita; Joshi, Amit; Raja, Anand; Bradoo, Anil; Ramesh, Anita; Kumar, Anup; Agrawal, Archi; Ambekar, Asawari; Joshi, Ashish; Singh, Ashish; Singh, Bhupendra Pal; Dabkara, Deepak; Khadakban, Dhiraj; Gautam, Gagan; Prakash, Gagan; Pahwa, Harvinder Singh; Goel, Hemant Kumar; Kulkarni, Jagdeesh; Mishra, Jeeban Jyoti; Patel, Kaushal; Pal, Mahendra; Chibber, Percy Jal; Tiwari, Priya; Naik, Radheshyam; Raghunath, S K; Krishnatry, Rahul; Shimpi, Rajendra; Sharma, Rakesh; Taran, Rakesh; Trivedi, Sameer; Nabar, Sanjay; Surekha, Sanjoy; Kumar, Satish; Sawaimoon, Satyakam Krishna; Raina, Shailesh; Narasimha, Srivatsa; Advani, Suresh; Ghouse, Syed Mohammed; Muddu, Vamshi Krishna; Maniar, Vashishth; Venkat, Vivek; Murthy, Vedang.
Afiliação
  • Bakshi G; Department of Uro-Oncology, P D Hinduja National Hospital, Mumbai, India.
  • Tongaonkar H; Director of Surgical Oncology and Uro-Oncology, Max Nanavati Hospital, Mumbai, India.
  • Addla S; Department of Uro-Oncology, Apollo Hospital, Hyderabad, India.
  • Menon S; Department of Uro-Onco Pathology, Tata Memorial Hospital & HBNI, Mumbai, India.
  • Pradhan A; Department of Uro-Oncology, BL Kapoor Hospital, Delhi, India.
  • Kumar A; Department of Uro-Oncology, Narayana Health, Kolkata, India.
  • Bapat A; Department of Urology, Bapat Urology Hospital, Mumbai, India.
  • Gore A; Department of Medical Oncology, Prince Aly Khan Hospital, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
  • Raja A; Department of Uro-Oncology, Cancer Institute (WIA), Adyar, Chennai, India.
  • Bradoo A; Department of Urology, Excel Urology Centre, Mumbai, India.
  • Ramesh A; Department of Medical Oncology, Apollo Hospital, Chennai, India.
  • Kumar A; Department of Urology, Safdarjung Hospital, Delhi, India.
  • Agrawal A; Department of Nuclear Medicine, Tata Memorial Hospital & HBNI, Mumbai, India.
  • Ambekar A; Department of Pathology, Apollo Hospital, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India.
  • Singh A; Department of Medical Oncology, Christian Medical College, Vellore, India.
  • Singh BP; Department of Urology, King George Medical University, Lucknow, India.
  • Dabkara D; Department of Medical Oncology, Tata Memorial Centre, Kolkata, India.
  • Khadakban D; Department of Surgical Oncology, Oncolife Hospital, Satara, India.
  • Gautam G; Department of Uro-Oncology, Max Healthcare, Delhi, India.
  • Prakash G; Department of Uro-Oncology, Tata Memorial Hospital & HBNI, Mumbai, India.
  • Pahwa HS; Department of Uro-Oncology, King George Medical University, Lucknow, India.
  • Goel HK; Department of Urology, RML Hospital, Delhi, India.
  • Kulkarni J; Department of Uro-Oncology, Breach Candy Hospital, Mumbai, India.
  • Mishra JJ; Department of Uro-Oncology, VSS Hospital, Bhubaneshwar, India.
  • Patel K; Department of Medical Oncology, Tristar Hospital, Surat, India.
  • Pal M; Department of Uro-Oncology, Tata Memorial Hospital & HBNI, Mumbai, India.
  • Chibber PJ; Department of Urology, Jaslok Hospital, Mumbai, India.
  • Tiwari P; Department of Medical Oncology, Artemis Hospital, Delhi, India.
  • Naik R; Department of Medical Oncology, HCG Hospital, Bangalore, India.
  • Raghunath SK; Department of Uro-Oncology, HCG Hospital, Bangalore, India.
  • Krishnatry R; Department of Radiation Oncology, Tata Memorial Hospital & HBNI, Mumbai, India.
  • Shimpi R; Department of Uro-Oncology, Ruby Hall Clinic, Pune, India.
  • Sharma R; Department of Uro-Oncology, Indo-American Hospital, Hyderabad, India.
  • Taran R; Department of Medical Oncology, CHL Hospital, Indore, India.
  • Trivedi S; Department of Urology, Institute of Medical Science, Varanasi, India.
  • Nabar S; Department of Urology, Nanavati Hospital, Mumbai, India.
  • Surekha S; Department of Urology, SGPGI, Lucknow, India.
  • Kumar S; Department of Surgical Oncology, Mohan's Medicity Hospital, Madurai, India.
  • Sawaimoon SK; Department of Pathology, Apollo Hospital, Mumbai, India.
  • Raina S; Department of Urology, Lilavati Hospital, Mumbai, India.
  • Narasimha S; Department of Uro-Oncology, Sri Shankara Hospital, Bangalore, India.
  • Advani S; Department of Medical Oncology, SL Raheja Hospital, Mumbai, India.
  • Ghouse SM; Department of Uro-Oncology, AINU Hospital, Hyderabad, India.
  • Muddu VK; Department of Medical Oncology, Apollo Hospital, Hyderabad, India.
  • Maniar V; Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India.
  • Venkat V; Department of Urology, Nanavati Hospital, Mumbai, India.
  • Murthy V; Department of Radiation Oncology, Tata Memorial Hospital & HBNI, Mumbai, India.
Indian J Cancer ; 59(Supplement): S19-S45, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35343189
ABSTRACT
To gain insights on the diverse practice patterns and treatment pathways for prostate cancer (PC) in India, the Urological Cancer Foundation convened the first Indian survey to discuss all aspects of PC, with the objective of guiding clinicians on optimizing management in PC. A modified Delphi method was used, wherein a multidisciplinary panel of oncologists treating PC across India developed a questionnaire related to screening, diagnosis and management of early, locally advanced and metastatic PC and participated in a web-based survey (WBS) (n = 62). An expert committee meeting (CM) (n = 48, subset from WBS) reviewed the ambiguous questions for better comprehension and reanalyzed the evidence to establish a revote for specific questions. The threshold for strong agreement and agreement was ≥90% and ≥75% agreement, respectively. Sixty-two questions were answered in the WBS; in the CM 31 questions were revoted and 4 questions were added. The panelists selected answers based on their best opinion and closest to their practice strategy, not considering financial constraints and access challenges. Of the 66 questions, strong agreement was reached for 17 questions and agreement was achieved for 22 questions. There were heterogeneous responses for 27 questions indicative of variegated management approaches. This is one of the first Indian survey, documenting the diverse clinical practice patterns in the management of PC in India. It aims to provide guidance in the face of technological advances, resource constraints and sparse high-level evidence.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Indian J Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Indian J Cancer Ano de publicação: 2022 Tipo de documento: Article